NVDA
NVIDIA Corporation
NVDA has the edge over VRRM overall, supported by stronger modeled upside and stronger fundamentals.
VRRM
Verra Mobility Corporation
VRRM trails on the overall score without a compensating advantage in the available component scores.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
VRRM Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Healthy | |
| Strong | |
| Under pressure |
VRRM's profitability and cash flow are currently healthy, but its revenue and balance sheet are under pressure.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA has the edge over VRRM in the historical PE scenario, which offers more potential upside but is not a forecast.
VRRM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 2.6x | $1.96 | — |
| Current | 8.2x | $1.96 | — |
| Cheap | 31x | $7.49 | +282% |
| Fair | 46x | $11.05 | +464% |
| Expensive | 111x | $26.65 | +1260% |
Historical ranges are pointers, not guarantees.
VRRM's PE is in its cheap range at 8.2x. On analysts' estimates for next year's earnings, today's price would be 2.6x.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
NVDA has the edge over VRRM on the outlook, with more favorable earnings and revenue expectations.
VRRM Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong decline | |
| Decline | |
| Strongly weakening | |
| Limited | |
| Low |
Analysts expect VRRM's earnings and revenue to decline, with profitability weakening. However, they disagree widely on these estimates.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over VRRM on earnings, with more consistent year-over-year improvement.
VRRM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.75 | +214% |
| Q3 2026 | $0.24 | -29% |
| Q2 2026 | $0.26 | 0% |
| Q1 2026 | $0.82 | +273% |
| Q4 2025 | $0.85 | +347% |
| Q3 2025 | $0.34 | -43% |
| Q2 2025 | $0.26 | -54% |
| Q1 2025 | $0.22 | -56% |
| Q4 2024 | $0.19 | -47% |
VRRM earned $0.24 per share over the past year, down 29% from the year before.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over VRRM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA's operating margin was 66% last quarter, up 5.4 points from the same quarter a year ago, near the top of its range since 2019.
VRRM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $28.3M | -21% |
| Q2 2026 | $25.8M | -22% |
| Q1 2026 | $27.3M | -13% |
| Q4 2025 | $32.7M | +0.7% |
| Q3 2025 | $35.7M | +26% |
| Q2 2025 | $33.2M | +15% |
| Q1 2025 | $31.4M | +19% |
| Q4 2024 | $32.4M | +17% |
VRRM's revenue has slid since its 2022 peak: $28M last quarter, down 21% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 232% | +22 points |
| Q2 2026 | -127% | -318 points |
| Q1 2026 | 190% | +7.2 points |
| Q4 2025 | 132% | +266 points |
| Q3 2025 | 210% | -16 points |
| Q2 2025 | 191% | -21 points |
| Q1 2025 | 182% | -24 points |
| Q4 2024 | -134% | -218 points |
VRRM has the edge over NVDA on profitability, with a higher operating margin.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over VRRM on cash flow, with more consistent year-over-year improvement.
VRRM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $89.4M | +83% |
| Q2 2026 | $32.6M | -19% |
| Q1 2026 | $9.6M | -77% |
| Q4 2025 | $5.7M | -73% |
| Q3 2025 | $49M | -42% |
| Q2 2025 | $40.3M | +55% |
| Q1 2025 | $41.7M | +108% |
| Q4 2024 | $21.6M | +12% |
VRRM still generates free cash flow, though less than at its 2026 peak: $137M over the past year.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has 24.3B diluted shares, down 1% from a year ago, with $55.3B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
VRRM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +175K shares |
| 1 year | -6% | -9.7M shares |
| 3 years | -10% | -17.4M shares |
| 5 years | -8% | -13.3M shares |
| Available history | -7.5% | -12.3M shares |
VRRM has the edge over NVDA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $1.3M |
| Q1 2026 | $50.2M |
| Q4 2025 | $133.4M |
| Q3 2025 | — |
| Q4 2024 | $148.5M |
| Q3 2024 | — |
| Q4 2023 | — |
VRRM spent $185M buying back its own shares over the past year.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA has the edge over VRRM on leverage, with a lower net debt burden relative to earnings.
VRRM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.7x | Elevated |
| Q2 2026 | 3.9x | Elevated |
| Q1 2026 | 2.9x | Moderate |
| Q4 2025 | 2.7x | Moderate |
| Q3 2025 | 3.2x | Elevated |
| Q2 2025 | 3.5x | Elevated |
| Q1 2025 | 3.7x | Elevated |
| Q4 2024 | 3.9x | Elevated |
VRRM's net debt is about 3.7 years of its operating earnings (EBITDA), up from 3.1 years a year ago.
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
VRRM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 18.4 | Oversold |
| Stochastic | 2.7 | Oversold |
VRRM's weekly RSI is 18 (oversold) and its Stochastic is 3 (oversold).
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA is trading at 21x earnings, a 25% discount to the Technology sector's median of 28x.
VRRM PE vs Technology Sector
| Metric | VRRM | Sector median | Relative |
|---|---|---|---|
| PE | 8.2x | 28x | 71% below |
| PE % | 3 | 35 | 32 pts below |
VRRM has the edge over NVDA on valuation relative to its sector.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has the edge over VRRM on trend strength, trading above more of its moving averages.
VRRM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.74 | 28% below |
| 20 week MA | $3.67 | 47% below |
| 50 week MA | $10.8 | 82% below |
| 100 week MA | $17.3 | 89% below |
| 200 week MA | $19.7 | 90% below |
VRRM is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA has the edge over VRRM on returns for 2026, with the stronger performance.
VRRM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $14.0 | $13.5 | -3.6% |
| 2021 | $13.5 | $15.2 | +12% |
| 2022 | $15.2 | $13.5 | -11% |
| 2023 | $13.5 | $23.0 | +71% |
| 2024 | $23.0 | $24.1 | +4.6% |
| 2025 | $24.1 | $22.5 | -6.6% |
| 2026 YTD | $22.5 | $1.96 | -91% |
VRRM has finished lower in three of the last six years. It's down 91% so far in 2026.